Between 1970 and 1995 the Yellow Card reporting scheme for adverse drug reactions was limited to medical practitioners.
Linked evidence
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates